Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion

Clinical trial NCT04271332 · UNKNOWN

Trial details

NCT number: NCT04271332
Sponsor: Clinical Research Associates, LLC
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

16P11.2 Deletion Syndrome

Start date: 2022-09-01
Primary completion: 2024-12-22
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.